Your browser doesn't support javascript.
loading
New-onset seizure during and after brain tumor excision: a risk assessment analysis.
Oushy, Soliman; Sillau, Stefan H; Ney, Douglas E; Damek, Denise M; Youssef, A Samy; Lillehei, Kevin O; Ormond, D Ryan.
Afiliação
  • Oushy S; Departments of1Neurosurgery and.
  • Sillau SH; Departments of1Neurosurgery and.
  • Ney DE; 2Neurology, University of Colorado School of Medicine, Aurora, Colorado.
  • Damek DM; 2Neurology, University of Colorado School of Medicine, Aurora, Colorado.
  • Youssef AS; Departments of1Neurosurgery and.
  • Lillehei KO; Departments of1Neurosurgery and.
  • Ormond DR; Departments of1Neurosurgery and.
J Neurosurg ; 128(6): 1713-1718, 2018 06.
Article em En | MEDLINE | ID: mdl-28753117
ABSTRACT
OBJECTIVE Prophylactic use of antiepileptic drugs (AEDs) in seizure-naïve brain tumor patients remains a topic of debate. This study aimed to characterize a subset of patients at highest risk for new-onset perioperative seizures (i.e., intraoperative and postoperative seizures occurring within 30 days of surgery) who may benefit from prophylactic AEDs. METHODS The authors conducted a retrospective case-control study of all adults who had undergone tumor resection or biopsy at the authors' institution between January 1, 2004, and June 31, 2015. All patients with a history of preoperative seizures, posterior fossa tumors, pituitary tumors, and parasellar tumors were excluded. A control group was matched to the seizure patients according to age (± 0 years). Demographic data, clinical status, operative data, and postoperative course data were collected and analyzed. RESULTS Among 1693 patients who underwent tumor resection or biopsy, 549 (32.4%) had never had a preoperative seizure. Of these 549 patients, 25 (4.6%) suffered a perioperative seizure (Group 1). A total of 524 patients (95.4%) who remained seizure free were matched to Group 1 according to age (± 0 years), resulting in 132 control patients (Group 2), at an approximate ratio of 15. There were no differences between the patient groups in terms of age, sex, race, relationship status, and neurological deficits on presentation. Histological subtype (infiltrating glioma vs meningioma vs other, p = 0.041), intradural tumor location (p < 0.001), intraoperative cortical stimulation (p = 0.004), and extent of resection (less than gross total, p = 0.002) were associated with the occurrence of perioperative seizures. CONCLUSIONS While most seizure-naïve brain tumor patients do not benefit from perioperative seizure prophylaxis, such treatment should be considered in high-risk patients with supratentorial intradural tumors, in patients undergoing intraoperative cortical stimulation, and in patients in whom subtotal resection is likely.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Convulsões / Neoplasias Encefálicas / Procedimentos Neurocirúrgicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Convulsões / Neoplasias Encefálicas / Procedimentos Neurocirúrgicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article